Hims & Hers Health (HIMS) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Hims & Hers Health (HIMS) do?
Hims & Hers Health Inc (HIMS) is a U.S.-listed company in Healthcare (Drug Manufacturers - Specialty & Generic). What it does: Operates a digital health platform connecting patients with licensed healthcare professionals. Sells direct-to-consumer telehealth consultations and personalized prescription treatments through a proprietary online. It is worth $3.76B on the market and sold $2.87B over the last year.
- Market cap
- $3.76B
- P/E ratio
- None (reported a loss)
- Annual sales
- $2.87B
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Brief updated
- Nov 07, 2026
Brands and businesses behind HIMS
- Hims: Sells men's personalized prescription treatments and wellness products through an online direct-to-consumer subscription model.
- Hers: Sells women's specialized healthcare, dermatology, and wellness prescriptions through an online subscription platform.
- Apostrophe: Provides custom prescription skincare treatments formulated by dermatologists and delivered via direct subscription orders.
HIMS’s flags, in plain English
Each flag is a number from Hims & Hers Health’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 07, 2026.
Still Climbing
Sales up 73.6% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.
Wide Gross Margin
Gross margin of 50% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.
Insiders Hold
Insiders own 9.2% of the company. The people who run the company own a meaningful slice of it, so they gain or lose along with other shareholders.
Debt Is Driving
Heavy debt, 439% of shareholder equity. The company owes a lot compared with what it earns. Lenders get paid before shareholders, which leaves management fewer options in a weak year.
2 more risk notes open with the free trial. Try it free for 7 days.
Questions about HIMS
How big is Hims & Hers Health?
Hims & Hers Health’s market cap is $3.76B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $2.87B: what customers paid the company over the last year, before any costs.
What is HIMS’s P/E ratio?
HIMS has no P/E ratio right now. The company reported a loss, so there is no yearly profit to price.
What could go wrong with HIMS?
FDA regulatory scrutiny of compounded GLP-1 weight-loss medications poses a direct threat to high-growth product offerings. That is one risk on Hims & Hers Health’s card. Its first risk flag is Debt Is Driving, explained above. The card holds 2 more risk notes for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Hims & Hers Health’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. HIMS’s filings on SEC.gov. The Margin Monkey is research, not advice.
